These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16379543)

  • 21. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system.
    Linfield DT; Rothberg MB; Pfoh ER; Noss R; Cassard L; Powers JC; Lipold L; Martinez KA
    Breast Cancer Res Treat; 2022 Sep; 195(2):153-160. PubMed ID: 35842521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations.
    Kelly K; Leventhal H; Marvin M; Toppmeyer D; Much J; Dermody J; Baran J; Schwalb M
    Genet Test; 2004; 8(2):139-47. PubMed ID: 15345111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative genetic testing affects surgical decision making in breast cancer patients.
    Lokich E; Stuckey A; Raker C; Wilbur JS; Laprise J; Gass J
    Gynecol Oncol; 2014 Aug; 134(2):326-30. PubMed ID: 24910453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
    Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
    BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.
    Robson M; Dabney MK; Rosenthal G; Ludwig S; Seltzer MH; Gilewski T; Haas B; Osborne M; Norton L; Gilbert F; Offit K
    Genet Test; 1997; 1(1):47-51. PubMed ID: 10464625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRCA1/2 genetic testing in the community setting.
    Chen WY; Garber JE; Higham S; Schneider KA; Davis KB; Deffenbaugh AM; Frank TS; Gelman RS; Li FP
    J Clin Oncol; 2002 Nov; 20(22):4485-92. PubMed ID: 12431973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic.
    Kishan AU; Gomez CL; Dawson NA; Dvorak R; Foster NM; Hoyt A; Hurvitz SA; Kusske A; Silver EL; Tseng C; McCloskey SA
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):634-641. PubMed ID: 27619940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.
    Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status.
    Moller P; Evans DG; Reis MM; Gregory H; Anderson E; Maehle L; Lalloo F; Howell A; Apold J; Clark N; Lucassen A; Steel CM
    Int J Cancer; 2007 Sep; 121(5):1017-20. PubMed ID: 17471561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
    Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
    Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching.
    Hallowell N; Foster C; Ardern-Jones A; Eeles R; Murday V; Watson M
    Genet Test; 2002; 6(2):79-87. PubMed ID: 12215246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations.
    Armstrong K; Stopfer J; Calzone K; Fitzgerald G; Coyne J; Weber B
    Genet Test; 2002; 6(2):115-8. PubMed ID: 12215250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?
    Audrain J; Rimer B; Cella D; Garber J; Peshkin BN; Ellis J; Schildkraut J; Stefanek M; Vogel V; Lerman C
    J Clin Oncol; 1998 Jan; 16(1):133-8. PubMed ID: 9440734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial.
    Klemp JR; O'Dea A; Chamberlain C; Fabian CJ
    Fam Cancer; 2005; 4(4):279-84. PubMed ID: 16341803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing in young women with breast cancer: results from a Web-based survey.
    Ruddy KJ; Gelber S; Shin J; Garber JE; Rosenberg R; Przypysny M; Partridge AH
    Ann Oncol; 2010 Apr; 21(4):741-747. PubMed ID: 19713245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.